Connor, Clark & Lunn Investment Management (CC&L)’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,492
Closed -$306K 1550
2025
Q2
$306K Buy
+2,492
New +$285K ﹤0.01% 1352
2024
Q4
Sell
-18,397
Closed -$1.78M 1458
2024
Q3
$1.78M Buy
+18,397
New +$1.65M 0.01% 701
2021
Q4
Sell
-66,615
Closed -$3.98M 1110
2021
Q3
$3.98M Buy
+66,615
New +$4.19M 0.02% 386
2020
Q3
Sell
-12,971
Closed -$639K 978
2020
Q2
$639K Buy
+12,971
New +$700K ﹤0.01% 708
2020
Q1
Sell
-85,193
Closed -$4.7M 1053
2019
Q4
$4.7M Sell
85,193
-51,380
-38% -$2.79M 0.03% 282
2019
Q3
$6.88M Buy
136,573
+27,905
+26% +$1.4M 0.05% 219
2019
Q2
$5.48M Buy
108,668
+28,723
+36% +$1.39M 0.04% 269
2019
Q1
$3.71M Sell
79,945
-14,330
-15% -$726K 0.02% 316
2018
Q4
$4.63M Buy
94,275
+17,661
+23% +$1M 0.03% 278
2018
Q3
$4.75M Buy
76,614
+52,102
+213% +$3.17M 0.03% 316
2018
Q2
$1.32M Buy
+24,512
New +$1.23M 0.01% 561

Other funds holding EHC

Connor, Clark & Lunn Investment Management (CC&L)'s EHC Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 2,492 shares — an estimated $306K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in EHC in Q2 2018 and held it in 11 quarters. The position peaked at $6.88M in Q3 2019. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 2,492 Encompass Health shares in Q3 2025, an estimated $306K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Encompass Health in Q2 2018 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Encompass Health position peaked at $6.88M in Q3 2019.
  • 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.